why choose us

Clinical Trials Search

Showing 14,280 of 132,963 result(s)
A Study of DB-OTO, an AAV Based Gene Therapy, in Children;Infants With Hearing Loss Due to Otoferlin Mutations

Status: Completed

Condition: Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

Interventions:

DB-OTO will be administered as a single intracochlear injection into one ear (Part A).

  • LD Cohort (starting dose)
  • HD Cohort (high

    Date: 2023-03-15

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and;or an Autoinflammatory Condition

Status: Completed

Condition: Primary Immune Regulatory Disorder

Interventions: Emapalumab on Days -22 (22 days before the day of the stem cell transplant), -15, -8, and -1.

Date: 2023-03-15

The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads

Status: Completed

Condition: Head and Neck Cancer

Interventions: SNAP includes 2 educational survivorship modules for caregivers and survivors.
There are 3 main elements: needs assessment, a tailored care plan

Date: 2023-03-15

Hypothermia's Effect on Hepatitis B Vaccination

Status: Completed

Condition: Hypoxic-Ischemic Encephalopathy

Interventions: Subject's who will be treated with the hypothermia protocol for Hypoxic Ischemic Encephalopathy as standard of care.

Date: 2023-03-15

Postprandial Monocyte Study

Status: Completed

Condition: Immune System

Interventions: High saturated fat challenge meal made with palm oil

Date: 2023-03-15

Safety and Efficacy of Empagliflozin in Hemodialysis

Status: NOT_YET_RECRUITING

Condition: End Stage Renal Disease

Interventions: Sodium glucose cotransporter 2 inhibitor (SGLT2i) dosed once-daily over 12 weeks.
Administered as oral tablet.

Date: 2023-03-15

A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma

Status: Completed

Condition: Mantle Cell Lymphoma

Interventions: Participants will receive treatment with intravenous tafasitamab and oral lenalidomide for up to 12 cycles.
Each cycle is 28 days in length.

Date: 2023-03-15

Immediate and 24-hour Effects of HyperVolt, Body Tempering, and Cupping Compared to Stretching on Hamstring Flexibility

Status: Completed

Condition: Hamstring Contractures

Interventions: HyperVolt Percussive Massage Device: this will be performed by a physical therapist while the participant is prone.
The physical therapist will a

Date: 2023-03-15

Developing a Decision Tool for Diverticulitis in the Emergency Department Using Ultrasound

Status: Completed

Condition: Diverticulitis

Interventions: Point-of-care ultrasound in the emergency department

Date: 2023-03-15

Virtual Reality Cognitive Therapy for Alzheimer's Disease

Status: Completed

Condition: Alzheimer Disease

Interventions: The VRCT will focus primarily on skills that impact instrumental activities of daily living (e.g., taking medications, shopping).
Thirty-six indi

Date: 2023-03-15